Yuki Gosei Kogyo Co., Ltd.

Yuki Gosei Kogyo Co., Ltd.

TTSE:4531
371.00
JPY
+4.00
(+1.09%)
8.43BMarket Cap
Oct 30Next Earn
Yuki Gosei Kogyo Co., Ltd.
TSE:4531
(Tokyo Stock Exchange)

Recent

price

371.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
426.75
371.59
394.17
431.47
458.24
484.51
476.26
461.48
470.61
491
508.15
566.36
588.29
592.57
698.53
715.59
- -
Revenue per Share
-0.55
9.51
15.47
2.45
15.12
16.07
16.26
5.73
4.76
-1.92
13.2
11.36
25.48
35.56
41.37
14.5
- -
Basic EPS, GAAP
70.03
-53.55
31.42
48.04
38.38
-2.87
-65.19
-73.3
-62.49
43.71
-9.53
64.33
-22.45
-62.64
-50.51
80.05
- -
Free Cash Flow per Basic Share
2.02
0.03
- -
2.97
2.98
5
5.96
5.96
5.96
2.98
1.97
2.98
3.99
6.96
7.99
8.94
- -
Dividend per Share
401.89
419
445.49
457.68
476.08
483.66
500.08
509.64
498.97
482.67
501.52
504.15
525.89
569.53
608.32
623.96
- -
Book Value per Share
396.6
414.83
442.12
453.45
472.06
479.67
495.05
505.56
495.95
478.05
493.23
494.25
513.33
560.23
601.96
619.84
- -
Tangible Book Value per Share
22
22
22
22
22
22
22
22
22
22
22
22
22
22
22
22
22
Basic Weighted Avg Shares
9,322
8,117
8,609
9,423
10,005
10,576
10,396
10,073
10,272
10,717
11,091
12,361
12,839
12,932
15,128
15,448
- -
Sales/Revenue/Turnover
7.98
10.01
5.93
7.94
7.35
9.13
4.4
2.09
0.51
2.94
1.98
3.37
7.01
8.72
8.06
2.51
- -
Operating Margin (%)
856
866
750
560
512
520
632
658
889
940
962
897
928
977
1,034
1,238
- -
Depreciation Expense
-12
208
338
54
330
351
355
125
104
-42
288
248
556
776
896
313
- -
Net Income, GAAP
116.37
- -
48.07
78.86
11.36
22.78
11
25.44
26.24
- -
9.72
14.19
13.1
14.25
20.28
13.3
- -
Effective Tax Rate (%)
-0.13
2.56
3.92
0.57
3.3
3.32
3.41
1.24
1.01
-0.39
2.6
2.01
4.33
6
5.92
2.03
- -
Profit Margin (%)
2,481
3,031
3,625
4,922
5,020
4,378
3,779
2,768
2,783
2,746
3,179
3,393
3,218
4,103
4,578
5,044
- -
Working Capital
810
1,167
699
2,407
2,273
1,759
2,017
3,054
2,483
2,061
1,819
1,481
1,145
2,240
4,112
2,497
- -
LT Debt
8,779
9,152
9,729
9,994
10,393
10,558
10,916
11,124
10,891
10,535
10,946
11,003
11,477
12,429
13,105
13,486
- -
Total Equity
-0.39
- -
0.03
0.35
1.44
2.5
2.69
0.93
0.21
- -
1.17
2.11
4.62
5.29
4.73
1.58
- -
Return on Invested Capital (%)
-0.17
- -
2.75
0.47
2.69
2.75
2.63
0.97
0.83
- -
2
1.73
3.57
4.51
4.69
2.09
- -
Return on Capital (%)
-0.14
2.32
3.58
0.54
3.24
3.35
3.31
1.13
0.94
-0.39
2.68
2.26
4.95
6.49
7.02
2.35
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
4,314
4,248
- -
LT Borrowings
4,452
2,393
- -
LT Finance Leases
- -
104
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
22
22
22
Market Capitalization
6,182
8,429
7,781

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
12,902
13,044
- -
Cash, Cash Equivalents & STI
1,224
885
- -
Accounts Receivable, Net
3,465
3,333
- -
Inventories
7,639
8,141
- -
Total Current Liabilities
7,997
8,000
- -
Payables & Accruals
- -
- -
- -
ST Debt
4,314
4,248
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.53%
4.29%
2.91%
Free Cash Flow
86.52%
-201.77%
-257.95%
Net Income, GAAP
-90.62%
20.05%
-65.07%
Sales/Revenue/Turnover
4.01%
7.03%
2.12%
Total Cash Common Dividend
- -
37.02%
11.56%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
15,128
2026
- -
- -
- -
- -
15,448
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
41.37
2026
- -
- -
- -
- -
14.5
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
7.99
2026
- -
- -
- -
- -
8.94
2027
- -
- -
- -
- -
- -
Business
Yuki Gosei Kogyo Co., Ltd. manufactures and markets fine organic chemicals, including amino acids, pharmaceuticals, food additives, and industrial chemicals; key products comprise glycine and glycine compounds, beta-alanine, nicotinic acid amide, isoniazid, protamine sulfate, DNA and nucleosides, 2-vinylpyridine, 3-cyanopyridine, 8-hydroxyquinoline, organosilicon compounds for semiconductors and ship paints, pyridine derivatives for tire cord adhesives, amino acid derivatives as chelating agents, agricultural chemical intermediates, and cosmetic ingredients; the company also provides contract manufacturing of pharmaceuticals and chemicals through subsidiaries. Founded in 1947 and headquartered in Tokyo, Japan, with facilities including the Joban Factory, Tokyo Research Laboratory, and a Düsseldorf Office, Yuki Gosei Kogyo operates primarily in Japan and internationally, serving pharmaceutical, food, industrial, agricultural, and semiconductor sectors. Listed on the Tokyo Stock Exchange Standard Market (4531.T), the company maintains an affiliated entity, Yuki Techno Service Co., Ltd., and employs 296 staff as of March 31, 2025. In 2025, Yuki Gosei Kogyo installed additional glycine production facilities at the Joban Factory and received an EcoVadis Silver Medal for CSR performance, following a Gold Medal in 2024; it also holds certifications including FSSC 22000 (2021), ISO 9001, and ISO 14001.